The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer
- 31 October 1999
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 45 (3), 553-561
- https://doi.org/10.1016/s0360-3016(99)00235-7
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- PSA for outcome prediction and posttreatment evaluation following radiation for prostate cancer: Do we know how to use it?Seminars in Radiation Oncology, 1998
- Radiotherapy for localized prostate carcinomaCancer, 1997
- Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical controlInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Prostate-specific antigen and radiation therapy for clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Prostatic-specific antigen doubling times in patients with prostate cancer: A potentially useful reflection of tumor doubling timeInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapyCancer, 1993
- Prostate Specific Antigen after External Beam Radiotherapy for Prostatic Cancer: FollowupJournal of Urology, 1993
- Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implicationsCancer, 1993
- Prostate Specific Antigen in the Management of Patients with Localized Adenocarcinoma of the Prostate Treated with Primary Radiation TherapyJournal of Urology, 1991